Not recruiting
Plasma cell myeloma
Not recruitingStudy on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant
Registered drugNo placebo
Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant
Registered drugNo placebo
- Disease:Plasma cell myeloma
- Substances:EvencaleucelIsatuximab
Countries:
Sweden
Sweden- Participants:18–64 years · 65+ years
- Substances:Evencaleucel
